Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients

• Status: Completed
• Trial end date: 2010-06-09
• Target enrollment: 0
• Participant gender: All

Summary

This is an interventional randomized, controlled trial in analyzing the effects of astaxanthin supplementation on plasma malondialdehyde levels and NIHSS of acute ischemic stroke patients. According to published studies, it was hypothesized that acute ischemic stroke patients who were given astaxanthin would have lower plasma malondialdehyde levels and lower NIHSS score compared to the control group.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Indonesia University

Criteria

Inclusion Criteria:

• 40-65 years old

• Has acute ischemic stroke with an onset of less than 48 hours before hospital admission

• NIHSS score of less than or equal to 15

• Can consume food orally or enterally

• Has given their consent to be a participant in the study

Exclusion Criteria:

• Renal failure

• Liver failure

• Is taking supplements other than his or her main stroke medications

• Has taken antioxidant supplements in the last 3 months before stroke onset